TCTAP 2014

Lilly Korea/Daiichi Sankyo Korea

The 10th largest pharmaceutical company in the world, Lilly has remained dedicated to creating medicines that help improve peoples' quality of life for more than 135 years. At the heart of Lilly's operations are its core values - excellence, integrity and respect for people.

4th Floor STX Namsan Tover, 631, Namdaemunro-5ga
+82-2-3459-2600
http://www.lilly.co.kr

Booth No. E039

Exhibition Item
Effient® (prasugrel) is indicated to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) who are to be managed with PCI.

Satellite Symposium

Tailored Antiplatelet Treatment Using Effient
Organized by CVRF and Supported Through an Unlimited Educational Grant from Daiichi-Sankyo Korea & Lilly Korea
Wednesday, April 23 12:45 PM - 1:45 PM Room 3-2, Level 3
Moderator(s): Myung-Ho Jeong
Panelist(s): Sung Gyun Ahn, Sang Hyun Kim, Jin Bae Lee, Sang-Rok Lee, Keon-Woong Moon, Woo Jung Park, Jung-Won Suh, Tae-Hyun Yang

12:45 PM	Opening Remark Speaker : Myung-Ho Jeong
12:50 PM	EU Perspectives: How EU Physicians Make Decisions on Antiplatelet Agent Lecturer : Jean-Philippe Collet
1:10 PM	Discussion
1:15 PM	Update on Relationship Between Platelet Reactivity and Clinical Outcomes: How to Select Optimal Patients for Prasugrel? Lecturer : Young-Hoon Jeong
1:40 PM	Discussion and Closing